Philina Lee
Director/Board Member at FUSN PHAR
Net worth: 3 M $ as of 2024-04-29
Philina Lee active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FUSN PHAR | Director/Board Member | 2021-02-10 | - |
| Independent Dir/Board Member | 2021-02-10 | - | |
| BLUEPRINT MEDICINES CORPORATION | Corporate Officer/Principal | 2020-12-31 | - |
Career history of Philina Lee
Former positions of Philina Lee
| Companies | Position | Start | End |
|---|---|---|---|
| ALGETA ASA | Corporate Officer/Principal | - | - |
Training of Philina Lee
| University of Alberta | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistics
International
| Canada | 3 |
| United States | 3 |
| Norway | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| FUSN PHAR | Health Technology |
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
- Stock Market
- Insiders
- Philina Lee
- Experience
